Epinastine Market – Antihistamine Option for Allergic...

agregó una foto Health

2026-07-21 08:04:48 -

Epinastine Market – Antihistamine Option for Allergic Conjunctivitis and Rhinitis

Market Overview The epinastine market continues to grow modestly as this second-generation antihistamine remains widely used for treating allergic conjunctivitis and, in some formulations, allergic rhinitis. Growth through 2030 is supported by rising global allergy prevalence, continued demand for dual-action antihistamine and mast cell stabilizer therapies, and expanding generic manufacturing...

0 Commentarios 0 Acciones 11 Views 0 Vista previa